Pioglitazone

NDC 57237-220 · Rising Pharma Holdings, Inc.

Generic namePioglitazone

Dosage formTABLET

RouteORAL

Active ingredient(s)PIOGLITAZONE HYDROCHLORIDE

Strength30 mg/1

Pharmacologic classPeroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator Receptor gamma Agonist [EPC], Peroxisome Proliferator-activated Receptor alpha Agonists [MoA], Peroxisome Proliferator-activated Receptor gamma Agonists [MoA], Thiazolidinedione [EPC], Thiazolidinediones [CS]

Marketing categoryANDA

Packages

57237-220-05 — 500 TABLET in 1 BOTTLE (57237-220-05)

57237-220-30 — 30 TABLET in 1 BOTTLE (57237-220-30)

57237-220-90 — 90 TABLET in 1 BOTTLE (57237-220-90)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

50090-6384 — pioglitazone hydrochloride, 50090-6386 — pioglitazone hydrochloride, 50090-6393 — pioglitazone hydrochloride, 50090-6412 — Pioglitazone, 50090-6873 — Pioglitazone, 50090-6874 — Pioglitazone, 50090-7846 — pioglitazone hydrochloride, 57237-217 — Pioglitazone Hydrochloride and Metformin Hydrochloride, 57237-218 — Pioglitazone Hydrochloride and Metformin Hydrochloride, 57237-219 — Pioglitazone, 57237-221 — Pioglitazone, 60687-391 — Pioglitazone, 60687-905 — Pioglitazone, 62135-804 — PIOGLITAZONE HYDROCHLORIDE, 62135-805 — PIOGLITAZONE HYDROCHLORIDE, 62135-806 — PIOGLITAZONE HYDROCHLORIDE, 64764-123 — alogliptin and pioglitazone, 64764-151 — pioglitazone, 64764-158 — pioglitazone and metformin hydrochloride, 64764-251 — alogliptin and pioglitazone, +68 more

From the FDA National Drug Code Directory, retrieved 2026-08-24. Product listings are submitted by labelers; FDA does not verify them.